Ethical Challenges in COVID-19 Biospecimen Research: Perspectives From Institutional Review Board Members and Bioethicists
Biospecimen research is a prominent investigative strategy that aims to provide novel insights into coronavirus disease 2019 (COVID-19), inform clinical trials, and develop effective, life-saving treatments. However, COVID-19 biospecimen research raises accompanying ethical concerns and practical ch...
Gespeichert in:
| Veröffentlicht in: | Mayo Clinic proceedings 2021-01, Vol.96 (1), p.165-173 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 173 |
|---|---|
| container_issue | 1 |
| container_start_page | 165 |
| container_title | Mayo Clinic proceedings |
| container_volume | 96 |
| creator | Lapid, Maria I Meagher, Karen M Giunta, Hannah C Clarke, Bart L Ouellette, Yves Armbrust, Tamyra L Sharp, Richard R Wright, R Scott |
| description | Biospecimen research is a prominent investigative strategy that aims to provide novel insights into coronavirus disease 2019 (COVID-19), inform clinical trials, and develop effective, life-saving treatments. However, COVID-19 biospecimen research raises accompanying ethical concerns and practical challenges for investigators and participants. In this special article, we discuss the ethical issues that are associated with autonomy, beneficence, and justice in COVID-19 biospecimen research and describe strategies to manage the practical challenges, with an emphasis on protecting the rights and welfare of human research participants during a pandemic response. Appropriate institutional review board oversight and bioethics guidance for COVID-19 biospecimen research must maintain their focus on protecting the rights and welfare of research participants, despite the urgent need for more knowledge about the virus and the threat it poses to communities and nations. |
| doi_str_mv | 10.1016/j.mayocp.2020.10.021 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7584427</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A657380774</galeid><sourcerecordid>A657380774</sourcerecordid><originalsourceid>FETCH-LOGICAL-g367t-529b09127b4c1e1b9b536e301be44bf7897d8406e69ec279bfeabc811b22ca5e3</originalsourceid><addsrcrecordid>eNp1kU1v1DAQhiMEokvhHyCUE-KSYDv-iDkgtUtbVioqqoBrZDuTjSvHXmJnofx6krYg9oB8sPT6mceamSx7iVGJEeZvb8pB3QazKwkiS1Qigh9lKywpKRij_HG2QoiwgmPJj7JnMd4ghISU9Gl2VFUUVzVmq-zXWeqtUS5f98o58FuIufX5-urb5kOBZX5qQ9yBsQP4_BoiqNH07_LPMC5psvsZPx_DkG98TDZNyQY_y65hb-FHfhrU2OafYNAznyvfLjpYPrQxxefZk065CC8e7uPs6_nZl_XH4vLqYrM-uSy2FRepYERqJDERmhoMWEvNKg4Vwhoo1Z2opWhrijhwCYYIqTtQ2tQYa0KMYlAdZ-_vvbtJD9Aa8GlUrtmNdlDjbROUbQ5fvO2bbdg3gtWUEjEL3jwIxvB9gpiawUYDzikPYYoNoYIzjli1oOU9ulUOGuu7MBvNfFoYrAkeOjvnJ5yJqkZC0Lng9UHBzCT4mbZqirH5P9iDcqmPwd1NPB6Cr_5t92-ff3Ze_QaT1rBT</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2476560537</pqid></control><display><type>article</type><title>Ethical Challenges in COVID-19 Biospecimen Research: Perspectives From Institutional Review Board Members and Bioethicists</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Lapid, Maria I ; Meagher, Karen M ; Giunta, Hannah C ; Clarke, Bart L ; Ouellette, Yves ; Armbrust, Tamyra L ; Sharp, Richard R ; Wright, R Scott</creator><creatorcontrib>Lapid, Maria I ; Meagher, Karen M ; Giunta, Hannah C ; Clarke, Bart L ; Ouellette, Yves ; Armbrust, Tamyra L ; Sharp, Richard R ; Wright, R Scott</creatorcontrib><description>Biospecimen research is a prominent investigative strategy that aims to provide novel insights into coronavirus disease 2019 (COVID-19), inform clinical trials, and develop effective, life-saving treatments. However, COVID-19 biospecimen research raises accompanying ethical concerns and practical challenges for investigators and participants. In this special article, we discuss the ethical issues that are associated with autonomy, beneficence, and justice in COVID-19 biospecimen research and describe strategies to manage the practical challenges, with an emphasis on protecting the rights and welfare of human research participants during a pandemic response. Appropriate institutional review board oversight and bioethics guidance for COVID-19 biospecimen research must maintain their focus on protecting the rights and welfare of research participants, despite the urgent need for more knowledge about the virus and the threat it poses to communities and nations.</description><identifier>ISSN: 0025-6196</identifier><identifier>ISSN: 1942-5546</identifier><identifier>EISSN: 1942-5546</identifier><identifier>DOI: 10.1016/j.mayocp.2020.10.021</identifier><identifier>PMID: 33413815</identifier><language>eng</language><publisher>England: Elsevier, Inc</publisher><subject>Analysis ; Bioethics ; Biological Specimen Banks ; Biological specimens ; Biomedical Research - ethics ; Coronaviruses ; COVID-19 - virology ; Ethical aspects ; Ethicists ; Ethics Committees, Research ; Ethics, Research ; Humans ; Laws, regulations and rules ; Medical ethics ; Medical research ; Medicine, Experimental ; Pandemics ; SARS-CoV-2 ; Special</subject><ispartof>Mayo Clinic proceedings, 2021-01, Vol.96 (1), p.165-173</ispartof><rights>Copyright © 2020 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.</rights><rights>COPYRIGHT 2021 Elsevier, Inc.</rights><rights>2020 Mayo Foundation for Medical Education and Research. 2020 Mayo Foundation for Medical Education and Research</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,777,781,882,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33413815$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lapid, Maria I</creatorcontrib><creatorcontrib>Meagher, Karen M</creatorcontrib><creatorcontrib>Giunta, Hannah C</creatorcontrib><creatorcontrib>Clarke, Bart L</creatorcontrib><creatorcontrib>Ouellette, Yves</creatorcontrib><creatorcontrib>Armbrust, Tamyra L</creatorcontrib><creatorcontrib>Sharp, Richard R</creatorcontrib><creatorcontrib>Wright, R Scott</creatorcontrib><title>Ethical Challenges in COVID-19 Biospecimen Research: Perspectives From Institutional Review Board Members and Bioethicists</title><title>Mayo Clinic proceedings</title><addtitle>Mayo Clin Proc</addtitle><description>Biospecimen research is a prominent investigative strategy that aims to provide novel insights into coronavirus disease 2019 (COVID-19), inform clinical trials, and develop effective, life-saving treatments. However, COVID-19 biospecimen research raises accompanying ethical concerns and practical challenges for investigators and participants. In this special article, we discuss the ethical issues that are associated with autonomy, beneficence, and justice in COVID-19 biospecimen research and describe strategies to manage the practical challenges, with an emphasis on protecting the rights and welfare of human research participants during a pandemic response. Appropriate institutional review board oversight and bioethics guidance for COVID-19 biospecimen research must maintain their focus on protecting the rights and welfare of research participants, despite the urgent need for more knowledge about the virus and the threat it poses to communities and nations.</description><subject>Analysis</subject><subject>Bioethics</subject><subject>Biological Specimen Banks</subject><subject>Biological specimens</subject><subject>Biomedical Research - ethics</subject><subject>Coronaviruses</subject><subject>COVID-19 - virology</subject><subject>Ethical aspects</subject><subject>Ethicists</subject><subject>Ethics Committees, Research</subject><subject>Ethics, Research</subject><subject>Humans</subject><subject>Laws, regulations and rules</subject><subject>Medical ethics</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Pandemics</subject><subject>SARS-CoV-2</subject><subject>Special</subject><issn>0025-6196</issn><issn>1942-5546</issn><issn>1942-5546</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kU1v1DAQhiMEokvhHyCUE-KSYDv-iDkgtUtbVioqqoBrZDuTjSvHXmJnofx6krYg9oB8sPT6mceamSx7iVGJEeZvb8pB3QazKwkiS1Qigh9lKywpKRij_HG2QoiwgmPJj7JnMd4ghISU9Gl2VFUUVzVmq-zXWeqtUS5f98o58FuIufX5-urb5kOBZX5qQ9yBsQP4_BoiqNH07_LPMC5psvsZPx_DkG98TDZNyQY_y65hb-FHfhrU2OafYNAznyvfLjpYPrQxxefZk065CC8e7uPs6_nZl_XH4vLqYrM-uSy2FRepYERqJDERmhoMWEvNKg4Vwhoo1Z2opWhrijhwCYYIqTtQ2tQYa0KMYlAdZ-_vvbtJD9Aa8GlUrtmNdlDjbROUbQ5fvO2bbdg3gtWUEjEL3jwIxvB9gpiawUYDzikPYYoNoYIzjli1oOU9ulUOGuu7MBvNfFoYrAkeOjvnJ5yJqkZC0Lng9UHBzCT4mbZqirH5P9iDcqmPwd1NPB6Cr_5t92-ff3Ze_QaT1rBT</recordid><startdate>20210101</startdate><enddate>20210101</enddate><creator>Lapid, Maria I</creator><creator>Meagher, Karen M</creator><creator>Giunta, Hannah C</creator><creator>Clarke, Bart L</creator><creator>Ouellette, Yves</creator><creator>Armbrust, Tamyra L</creator><creator>Sharp, Richard R</creator><creator>Wright, R Scott</creator><general>Elsevier, Inc</general><general>Mayo Foundation for Medical Education and Research</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210101</creationdate><title>Ethical Challenges in COVID-19 Biospecimen Research: Perspectives From Institutional Review Board Members and Bioethicists</title><author>Lapid, Maria I ; Meagher, Karen M ; Giunta, Hannah C ; Clarke, Bart L ; Ouellette, Yves ; Armbrust, Tamyra L ; Sharp, Richard R ; Wright, R Scott</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g367t-529b09127b4c1e1b9b536e301be44bf7897d8406e69ec279bfeabc811b22ca5e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Analysis</topic><topic>Bioethics</topic><topic>Biological Specimen Banks</topic><topic>Biological specimens</topic><topic>Biomedical Research - ethics</topic><topic>Coronaviruses</topic><topic>COVID-19 - virology</topic><topic>Ethical aspects</topic><topic>Ethicists</topic><topic>Ethics Committees, Research</topic><topic>Ethics, Research</topic><topic>Humans</topic><topic>Laws, regulations and rules</topic><topic>Medical ethics</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Pandemics</topic><topic>SARS-CoV-2</topic><topic>Special</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lapid, Maria I</creatorcontrib><creatorcontrib>Meagher, Karen M</creatorcontrib><creatorcontrib>Giunta, Hannah C</creatorcontrib><creatorcontrib>Clarke, Bart L</creatorcontrib><creatorcontrib>Ouellette, Yves</creatorcontrib><creatorcontrib>Armbrust, Tamyra L</creatorcontrib><creatorcontrib>Sharp, Richard R</creatorcontrib><creatorcontrib>Wright, R Scott</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Mayo Clinic proceedings</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lapid, Maria I</au><au>Meagher, Karen M</au><au>Giunta, Hannah C</au><au>Clarke, Bart L</au><au>Ouellette, Yves</au><au>Armbrust, Tamyra L</au><au>Sharp, Richard R</au><au>Wright, R Scott</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ethical Challenges in COVID-19 Biospecimen Research: Perspectives From Institutional Review Board Members and Bioethicists</atitle><jtitle>Mayo Clinic proceedings</jtitle><addtitle>Mayo Clin Proc</addtitle><date>2021-01-01</date><risdate>2021</risdate><volume>96</volume><issue>1</issue><spage>165</spage><epage>173</epage><pages>165-173</pages><issn>0025-6196</issn><issn>1942-5546</issn><eissn>1942-5546</eissn><abstract>Biospecimen research is a prominent investigative strategy that aims to provide novel insights into coronavirus disease 2019 (COVID-19), inform clinical trials, and develop effective, life-saving treatments. However, COVID-19 biospecimen research raises accompanying ethical concerns and practical challenges for investigators and participants. In this special article, we discuss the ethical issues that are associated with autonomy, beneficence, and justice in COVID-19 biospecimen research and describe strategies to manage the practical challenges, with an emphasis on protecting the rights and welfare of human research participants during a pandemic response. Appropriate institutional review board oversight and bioethics guidance for COVID-19 biospecimen research must maintain their focus on protecting the rights and welfare of research participants, despite the urgent need for more knowledge about the virus and the threat it poses to communities and nations.</abstract><cop>England</cop><pub>Elsevier, Inc</pub><pmid>33413815</pmid><doi>10.1016/j.mayocp.2020.10.021</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0025-6196 |
| ispartof | Mayo Clinic proceedings, 2021-01, Vol.96 (1), p.165-173 |
| issn | 0025-6196 1942-5546 1942-5546 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7584427 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Analysis Bioethics Biological Specimen Banks Biological specimens Biomedical Research - ethics Coronaviruses COVID-19 - virology Ethical aspects Ethicists Ethics Committees, Research Ethics, Research Humans Laws, regulations and rules Medical ethics Medical research Medicine, Experimental Pandemics SARS-CoV-2 Special |
| title | Ethical Challenges in COVID-19 Biospecimen Research: Perspectives From Institutional Review Board Members and Bioethicists |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T09%3A20%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ethical%20Challenges%20in%20COVID-19%20Biospecimen%20Research:%20Perspectives%20From%20Institutional%20Review%20Board%20Members%20and%20Bioethicists&rft.jtitle=Mayo%20Clinic%20proceedings&rft.au=Lapid,%20Maria%20I&rft.date=2021-01-01&rft.volume=96&rft.issue=1&rft.spage=165&rft.epage=173&rft.pages=165-173&rft.issn=0025-6196&rft.eissn=1942-5546&rft_id=info:doi/10.1016/j.mayocp.2020.10.021&rft_dat=%3Cgale_pubme%3EA657380774%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2476560537&rft_id=info:pmid/33413815&rft_galeid=A657380774&rfr_iscdi=true |